Precigen (PGEN) Free Cash Flow (2012 - 2026)

Precigen's (PGEN) quarterly Free Cash Flow came in at -$44.0 million in Q1 2026, down 159.78% year-on-year from $73.6 million in Q1 2025, and down 87.52% on a QoQ basis from -$23.5 million in Q4 2025.

Precigen (PGEN) Free Cash Flow (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Free Cash Flow data on file, last reported at -$44.0 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 159.78% year-over-year to -$44.0 million in Q1 2026; TTM through Mar 2026 was -$116.9 million, a 74.43% decrease from a year earlier, with the FY2025 full-year figure at -$89.8 million, down 31.11% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$44.0 million, down from -$23.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PGEN reached as high as -$1.0 million in Q4 2024 and fell as low as -$44.0 million in Q1 2026.
  • Historically, Free Cash Flow has averaged -$20.0 million across 5 years, with a median of -$18.4 million in 2024.
  • Across the five-year window, Free Cash Flow jumped 93.51% in 2024 and slumped 2183.85% in 2025, its largest moves.
  • Year by year, Free Cash Flow stood at -$15.4 million in 2022, then fell by 2.54% to -$15.8 million in 2023, then soared by 93.51% to -$1.0 million in 2024, then slumped by 2183.85% to -$23.5 million in 2025, then tumbled by 87.52% to -$44.0 million in 2026.
  • Per Business Quant data, the three most recent Free Cash Flow figures were -$44.0 million in Q1 2026, -$23.5 million in Q4 2025, and -$30.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -44.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.03 Mn
Mar 31, 2026 -44.03 Mn
Dec 31, 2025 -23.48 Mn
Dec 31, 2025 -23.48 Mn
Sep 30, 2025 -30.79 Mn
Sep 30, 2025 -30.79 Mn
Jun 30, 2025 -18.61 Mn
Jun 30, 2025 -18.61 Mn
Mar 31, 2025 -16.95 Mn
Mar 31, 2025 -16.95 Mn
Dec 31, 2024 -1.03 Mn
Dec 31, 2024 -1.03 Mn
Sep 30, 2024 -23.62 Mn
Sep 30, 2024 -23.62 Mn
Jun 30, 2024 -25.43 Mn
Jun 30, 2024 -25.43 Mn
Mar 31, 2024 -18.44 Mn
Mar 31, 2024 -18.44 Mn
Dec 31, 2023 -15.84 Mn
Dec 31, 2023 -15.84 Mn